A new study finds that rising placebo responses may play a part in the increasingly high failure rate for clinical trials of drugs designed to control chronic pain caused by nerve damage.
The Mayday Fund has selected Jeffrey Mogil to be a fellow under the Mayday Pain & Society. He is one of six experts in pain management to receive the honour.
Pain researchers' arguments for using only male rodents in preclinical pain research don't hold up to scrutiny, says McGill neuroscientist Jeffrey Mogil. Nature
The ability to express empathy -- the capacity to share and feel another’s emotions -- is limited by the stress of being around strangers, according to a new study published today in the journal...
Injuries that result in chronic pain, such as limb injuries, and those unrelated to the brain are associated with epigenetic changes in the brain which persist months after the injury, according to...